XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net loss $ (18,921) $ (24,511)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 18,355 32,972
Depreciation and amortization 7,322 7,364
Amortization of right-of-use assets 2,671 2,816
Revaluation of contingent consideration to estimated fair value 547 529
Amortization of premium on short-term marketable securities, net 562 821
Other non-cash operating activities (7) 0
Changes in operating assets and liabilities:    
Accounts receivable (2,336) (15,207)
Inventory (6,741) (225)
Prepaid and other assets (4,170) 769
Operating leases liabilities, net (2,953) (2,882)
Accounts payable 1,625 (6,920)
Accrued compensation (19,303) 5,504
Accrued and other liabilities 5,544 2,693
Change in deferred revenue 1,116 0
Change in deferred taxes 0 (86)
Net cash (used in) provided by operating activities (16,689) 3,637
Investing activities:    
Purchases of short-term marketable securities (67,280) (93,212)
Maturities of short-term marketable securities 94,639 112,523
Additions of capital expenditures (2,637) (3,277)
Net cash provided by investing activities 24,722 16,034
Financing activities:    
Proceeds from issuance of common stock under employee stock purchase plan 2,272 532
Taxes paid related to net share settlement of restricted stock units (9,304) (4,266)
Proceeds from exercise of stock options 4,078 131
Payment of contingent consideration (1,500) (2,000)
Repurchase and retirement of common stock (50,000) (522)
Net cash used in financing activities (54,454) (6,125)
Effect of exchange rate changes on cash and cash equivalents (90) 41
Net (decrease) increase in cash, cash equivalents and restricted cash (46,511) 13,587
Cash, cash equivalents and restricted cash at beginning of period 115,274 82,783
Cash, cash equivalents and restricted cash at end of period $ 68,763 $ 96,370